drugset / Trial / NCT04174196
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate if the combination of CC-486 with lenalidomide and radiation therapy is a safe and effective treatment for plasmacytoma.
Timeline
- Start
- 2019-11-19
- Primary completion
- 2026-11-19
- Completion
- 2026-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CC-486 | Unknown | — | — |
| Subject | Lenalidomide | Other / unclassified | — | — |